| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |